Cathie Wood isn’t a stranger to bold bets, but her latest move could be one of her most intriguing.
The ARK Invest founder splurged $21.6 million on a biotech looking to end what parents and doctors have long called the “newborn guessing game.”
Instead of waiting for symptoms to emerge…